Colorescience® Announces Successful Completion of $15 Million Series C Preferred Stock Financing

CARLSBAD, Calif., Aug. 1, 2017 /PRNewswire/ -- Colorescience®, the leading dermatologist-recommended skin health cosmetics company, today announced the successful completion of a $15 Million Series C Preferred Stock financing led by 1315 Capital, L.P., a Philadelphia-based healthcare...